NCH Health: Cardiologist performs first transcatheter tricuspid valve replacement in Fla.
I am excited to announce that the NCH Rooney Heart Institute recently performed a groundbreaking procedure for patients with valvular heart disease.
The operation performed on March 21, by a highly specialized team led by Robert J. Cubeddu, MD, Harvard-trained interventional cardiologist and President of the NCH Rooney Heart Institute, represents the first-ever transcatheter tricuspid valve replacement performed in the State of Florida and one of 10 in the country after its recent approval by the U.S. Food and Drug Administration (FDA). Other physicians joining in this first-ever surgery in Florida were NCH Cardiovascular Surgeons David Axline, MD, Gaston Cudemus, MD, and Brian Solomon, MD.
This procedure, approved by the FDA, marks a significant advancement in cardiac care.
Tricuspid valve disease is highly prevalent and affects thousands of Americans with heart disease. The condition typically manifests as a malfunctioning leaky valve that when severe, often results in congestive heart failure and is associated with poor prognosis. Until recently, treatment options for tricuspid valve disease have been limited to drugs aimed at providing symptom relief only. However, with the introduction of the minimally invasive transcatheter approach using the "Evoque" valve manufactured by Edwards Lifescience, Inc., patients affected by this adverse condition now have access to a life-changing solution.
The self-expanding valve prosthesis is engineered from bovine pericardial tissue and is effectively delivered through a catheter inserted in the groin and maneuvered into the heart across the venous circulation. Once in position, the valve is carefully deployed replacing the function of the damaged tricuspid valve. The procedure takes approximately two hours and most patients recover quickly and are discharged home within two to three days.
The benefits of this procedure to our patients are profound. After undergoing this procedure, patients may experience improved quality of life, relief from debilitating symptoms such as fatigue and shortness of breath, and an enhanced ability to engage in physical activity. This achievement underscores our commitment to innovation and clinical excellence.
Naples Comprehensive Health (NCH) remains steadfast in our pursuit of continuously striving to provide patients with access to the latest advancements in cardiac care through innovation and research.
More New hospital grades out: How safe are you in Southwest Florida hospitals? What to know
And NCH's new Marco Island urgent care center gets underway with groundbreaking
This article originally appeared on Naples Daily News: NCH: Cardiologist performs first tricuspid valve replacement in Fla.
